Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...
The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...
The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...
Morning Overview on MSN
DNA-based system targets cancer cells and releases drugs at tumors
Researchers at the Université de Genève have built a DNA-based drug delivery system that reads pairs of protein markers on a cell’s surface, decides whether the cell is cancerous, and then floods it ...
Engineered cells are a high-value genetic asset that is key to many fields, including biotechnology, medicine, aging, and ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...
A research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a method to accurately and efficiently read DNA containing non-standard bases — a task once thought too ...
The National Academies of Sciences, Engineering, and Medicine (NASEM) will convene an ad hoc planning committee to organize a workshop series with international scientists. The series will engage ...
23andMe burst onto the scene by collecting saliva samples from millions of customers and revealing their ancestries, but it aspired to do much more: developing new medicines and providing personalized ...
An international research team led by scientists from Skoltech has developed a method to position molecules on the surface of ultrathin materials with unprecedented precision using molecular DNA ...
Twenty-seven entreaties drafted and endorsed following discussions at the 50-year anniversary summit of the 1975 Asilomar Conference on Recombinant DNA have been published and archived at Rice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results